We maintain our BUY recommendation on STI based on a target of Bt9.95 (previously Bt9.20), implying an upside of 22% from the current share price. We derive our target price from a DCF-based valuation using a WACC of 6.5% and a terminal growth rate of 3%. We apply a 15% small-cap discount.
Investment thesis:
Interim: Like the previous quarters, 4Q20 growth was largely due to the consolidation of AEC. Revenue was up by 123% YoY. Overall, the results confirm our expectations that the AEC acquisition is value accretive and provides high upside potential.
Risks: Reliance on limited industries, delay in project completion, shortage of experienced personnel, and adverse regulatory changes.
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.